(Q35190692)

7 August 2017

1 reference

title

Vaccination strategies for lymphomas (English)

1 reference

7 August 2017

2

Larry W Kwak

1 reference

7 August 2017

Mohammed M Dar

1

1 reference

7 August 2017

publication date

1 September 2003

1 reference

7 August 2017

published in

Current Oncology Reports

1 reference

7 August 2017

volume

5

1 reference

7 August 2017

issue

5

1 reference

7 August 2017

page(s)

380-386

1 reference

Tolerance, danger, and the extended family

7 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-003-0022-X

Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-003-0022-X

Innate immunity: impact on the adaptive immune response

21 January 2018

1 reference

12 December 2020

Tumor vaccination strategies combined with autologous peripheral stem cell transplantation

1 reference

12 December 2020

Plant viral genes in DNA idiotypic vaccines activate linked CD4+ T-cell mediated immunity against B-cell malignancies

1 reference

12 December 2020

Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma

1 reference

12 December 2020

An innate sense of danger

1 reference

12 December 2020

DNA Fusion Vaccine Designed to Induce Cytotoxic T Cell Responses Against Defined Peptide Motifs: Implications for Cancer Vaccines

1 reference

12 December 2020

ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1-restricted CD8+ T-cell epitopes

1 reference

12 December 2020

Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12

1 reference

12 December 2020

Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity

1 reference

12 December 2020

Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines

1 reference

12 December 2020

Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity

1 reference

12 December 2020

Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein

1 reference

12 December 2020

B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes

1 reference

12 December 2020

Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target

1 reference

12 December 2020

From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens

1 reference

12 December 2020

Cancer statistics, 2003.

1 reference

12 December 2020

Idiotype-encoding recombinant adenoviruses provide protective immunity against murine B-cell lymphomas

1 reference

12 December 2020

Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire

1 reference

12 December 2020

CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia

1 reference

12 December 2020

Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors

1 reference

12 December 2020

DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma

1 reference

12 December 2020

The role of CpG motifs in innate immunity

1 reference

12 December 2020

Increased potency of Fc-receptor-targeted antigens

1 reference

12 December 2020

Direct gene transfer into mouse muscle in vivo

1 reference

12 December 2020

Non-Hodgkin's lymphoma time trends: United States and international data

1 reference

12 December 2020

A genetic approach to idiotypic vaccination

1 reference

12 December 2020

Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma

1 reference

12 December 2020

The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells

1 reference

12 December 2020

Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma

1 reference

12 December 2020

Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.

1 reference

12 December 2020

Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor

1 reference

12 December 2020

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

12 December 2020

Idiotypic DNA vaccines against B-cell lymphoma

1 reference

12 December 2020

DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C

1 reference

12 December 2020

DNA fusion vaccines against B-cell tumors

1 reference

12 December 2020

Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial.

1 reference

12 December 2020

Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response

1 reference

12 December 2020

Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies

1 reference

12 December 2020

Idiotype vaccines for non-Hodgkin's lymphoma induce polyclonal immune responses that cover mutated tumor idiotypes: comparison of different vaccine formulations

1 reference

12 December 2020

Idiotype-cytokine fusion proteins as cancer vaccines. Relative efficacy of IL-2, IL-4, and granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory molecules.

1 reference

12 December 2020

4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine

1 reference

12 December 2020

Immunization with the light chain and the VL domain of the isologous myeloma protein 315 inhibits growth of mouse plasmacytoma MOPC315

1 reference

12 December 2020

Myeloma proteins as tumor-specific transplantation antigens

1 reference

12 December 2020

Stimulation of cytotoxic T cells against idiotype immunoglobulin of malignant lymphoma with protein-pulsed or idiotype-transduced dendritic cells

1 reference

12 December 2020

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

1 reference

12 December 2020

DNA immunization induces protective immunity against B-cell lymphoma

1 reference

12 December 2020

In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphoma

1 reference

12 December 2020

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

1 reference

12 December 2020

Inducing long-term survival with lasting anti-tumor immunity in treating B cell lymphoma by a combined dendritic cell-based and hydrodynamic plasmid-encoding IL-12 gene therapy

1 reference

12 December 2020

Chemokines and cell migration in secondary lymphoid organs

1 reference

12 December 2020

Liposomal formulation of a self lymphoma antigen induces potent protective antitumor immunity

1 reference

12 December 2020

The makings of a tumor rejection antigen

1 reference

12 December 2020

Protective and cellular immune responses to idiotypic determinants on cells from a spontaneous lymphoma of NZB-NZW F1 mice

1 reference

12 December 2020

Tumor Immunity Induced by Preimmunization With BALB/c Mouse Myeloma Protein2

1 reference

12 December 2020

10.1007/S11912-003-0022-X

Identifiers

DOI

1 reference

7 August 2017

1 reference